Calumenin (CALU), a protein which is involved in the regulation of vitamin K-dependent carboxylation of multiple amino-terminal glutamate residues and normally is present at very low levels in the brain, also was up-regulated in the 2 “AD-like” animals. Here, CALU is linked to Alzheimer disease.